Cargando…
Design and Synthesis of Hsp90 Inhibitors with B‐Raf and PDHK1 Multi‐Target Activity
The design of multi‐target ligands has become an innovative approach for the identification of effective therapeutic treatments against complex diseases, such as cancer. Recent studies have demonstrated that the combined inhibition of Hsp90 and B‐Raf provides synergistic effects against several type...
Autores principales: | Pinzi, Luca, Foschi, Francesca, Christodoulou, Michael S., Passarella, Daniele, Rastelli, Giulio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634768/ https://www.ncbi.nlm.nih.gov/pubmed/34633754 http://dx.doi.org/10.1002/open.202100131 |
Ejemplares similares
-
Structure-activity exploration of a small-molecule allosteric inhibitor of T790M/L858R double mutant EGFR
por: Foschi, Francesca, et al.
Publicado: (2022) -
Design of Dual Inhibitors of Histone Deacetylase 6
and Heat Shock Protein 90
por: Pinzi, Luca, et al.
Publicado: (2020) -
Synthesis of potent and selective HDAC6 inhibitors led to unexpected opening of a quinazoline ring
por: Moi, Davide, et al.
Publicado: (2022) -
The broad stroke of Hsp90 inhibitors: painting over the RAF inhibitor paradox
por: Vido, Michael, et al.
Publicado: (2015) -
On the development of B-Raf inhibitors acting through innovative mechanisms
por: Pinzi, Luca
Publicado: (2022)